Figure 3.
Effects of sFas gene delivery on myocardial expression of inflammatory mediators and oxidative damage in doxorubicin cardiotoxicity. A: Western blots for cyclooxygenase-2 (COX-2), MCP-1, and TGF-β1. B: Enzyme-linked immunosorbent assay for myocardial TNF-α. *P < 0.05 versus the sham group; #P < 0.05 versus the doxorubicin-treated group with LacZ gene transfer.